High incidence of advanced colorectal neoplasia during endoscopic surveillance in serrated polyposis syndrome

Abstract Background Serrated polyposis syndrome (SPS) has been associated with an increased risk of colorectal cancer (CRC). Accordingly, intensive surveillance with annual colonoscopy is advised. The aim of this multicenter study was to describe the risk of advanced lesions in SPS patients undergoing surveillance, and to identify risk factors that could guide the prevention strategy. Methods From March 2013 to April 2015, 296 patients who fulfilled criteria I and/or III for SPS were retrospectively recruited at 18 centers. We selected patients in whom successful clearing colonoscopy had been performed and who underwent subsequent endoscopic surveillance. Advanced neoplasia was defined as CRC, advanced adenoma, or advanced serrated lesion that were ≥ 10 mm and/or with dysplasia. Cumulative incidence of advanced neoplasia was calculated and independent predictors of advanced neoplasia development were identified. Results In 152 SPS patients a total of 315 surveillance colonoscopies were performed (median 2, range 1 – 7). The 3-year cumulative incidence of CRC and advanced neoplasia were 3.1 % (95 % confidence interval [CI] 0 – 6.9) and 42.0 % (95 %CI 32.4 – 51.7), respectively. Fulfilling both I + III criteria and the presence of advanced serrated lesions at baseline colonoscopy were independent predictors of advanced neoplasia development (odds ratio [OR] 1.85, 95 %CI 1.03 – 3.33, P  = 0.04 and OR 2.62, 95 %CI 1.18 – 5.81, P  = 0.02, respectively). During follow-up, nine patients (5.9 %) were referred for surgery for invasive CRC (n = 4, 2.6 %) or because of polyp burden (n = 5, 3.3 %). After total colectomy, 17.9 % patients developed advanced neoplasia in the retained rectum. Conclusions Patients with SPS have a substantial risk of developing advanced neoplasia under endoscopic surveillance, whereas CRC incidence is low. Personalized endoscopic surveillance based on polyp burden and advanced serrated histology could help to optimize prevention in patients with SPS.

[1]  J. Llach,et al.  Reassessment colonoscopy to diagnose serrated polyposis syndrome in a colorectal cancer screening population , 2016, Endoscopy.

[2]  E. Kuipers,et al.  Detection rate of serrated polyps and serrated polyposis syndrome in colorectal cancer screening cohorts: a European overview , 2016, Gut.

[3]  I. Nagtegaal,et al.  Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis , 2015, Gut.

[4]  J. Cubiella,et al.  Colorectal cancer risk factors in patients with serrated polyposis syndrome: a large multicentre study , 2015, Gut.

[5]  D. Ransohoff,et al.  Endoscopic detection of proximal serrated lesions and pathologic identification of sessile serrated adenomas/polyps vary on the basis of center. , 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  E. Dekker,et al.  Incidence of colonic neoplasia in patients with serrated polyposis syndrome who undergo annual endoscopic surveillance. , 2014, Gastroenterology.

[7]  Y. Hazewinkel.  Serrated polyps of the colon and rectum , 2014 .

[8]  David Lieberman,et al.  Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) Guideline , 2013, Endoscopy.

[9]  Peter Lance,et al.  Colorectal cancers soon after colonoscopy: a pooled multicohort analysis , 2013, Gut.

[10]  G. Capellá,et al.  [Hyperplastic polyposis syndrome: phenotypic diversity and association to colorectal cancer]. , 2013, Medicina clinica.

[11]  H. Pohl,et al.  Incomplete polyp resection during colonoscopy-results of the complete adenoma resection (CARE) study. , 2013, Gastroenterology.

[12]  Douglas K Rex,et al.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. , 2012, Gastroenterology.

[13]  D. Rex,et al.  Failure to recognize serrated polyposis syndrome in a cohort with large sessile colorectal polyps. , 2012, Gastrointestinal endoscopy.

[14]  K. Romans,et al.  Serrated polyposis: rapid and relentless development of colorectal neoplasia , 2012, Gut.

[15]  J. Church,et al.  Defining Phenotypes and Cancer Risk in Hyperplastic Polyposis Syndrome , 2011, Diseases of the colon and rectum.

[16]  Charles J Kahi,et al.  Prevalence and variable detection of proximal colon serrated polyps during screening colonoscopy. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[17]  E. Dekker,et al.  Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study , 2009, Gut.

[18]  F. Bosman,et al.  WHO Classification of Tumours of the Digestive System , 2010 .

[19]  L. Lipton,et al.  Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. , 2006, Gastroenterology.

[20]  C. Rubio,et al.  Hyperplastic polyposis coli syndrome and colorectal carcinoma. , 2006, Endoscopy.

[21]  N. Hyman,et al.  Hyperplastic Polyposis and the Risk of Colorectal Cancer , 2004, Diseases of the colon and rectum.

[22]  Randall W Burt,et al.  Phenotypic Characteristics and Risk of Cancer Development in Hyperplastic Polyposis: Case Series and Literature Review , 2004, American Journal of Gastroenterology.

[23]  M. Cravo,et al.  Management of Portuguese Patients with Hyperplastic Polyposis and Screening of At-Risk First-Degree Relatives: A Contribution for Future Guidelines Based on a Clinical Study , 2004, American Journal of Gastroenterology.